The Science Behind OceanicScore
Evidence-based programs.
Not wellness theater.
Every clinical track on OceanicScore is grounded in peer-reviewed research. The Oceanic Score itself is built from validated screening instruments and evidence-based risk frameworks. Here is the clinical basis for what we do and why it works.
Take the Evidence-Based Assessment →How the Oceanic Score is built
Four sub-scores.
Each grounded in validated instruments.
Each grounded in validated instruments.
Metabolic Sub-Score
BMI, waist circumference, blood glucose history, HOMA-IR estimate, family history, dietary pattern, activity level. Informed by ADA, ACC/AHA risk frameworks.
Hormonal Sub-Score
ADAM questionnaire (validated TRT screening), energy, libido, muscle maintenance, mood, sleep quality, last lab date. Correlates with established low-T diagnostic criteria.
Recovery Sub-Score
Pain location, duration, severity, mobility, sleep disruption, prior care, stress level. Aligned with Oswestry Disability Index and PROMIS physical function measures.
Vitality Sub-Score
Sleep quality and duration (Pittsburgh Sleep Quality Index items), supplement status, cognitive clarity, activity level, biomarker testing recency, dietary quality.
Clinical evidence by track
Peer-reviewed research
behind every plan.
behind every plan.
GLP-1 + Metabolic
Semaglutide produces 15–20% body weight reduction in clinical trials
STEP trials (NEJM 2021) demonstrated 14.9% mean weight loss with semaglutide vs 2.4% placebo over 68 weeks. Tirzepatide (SURMOUNT-1, NEJM 2022) showed up to 22.5% reduction. OceanicScore routes eligible patients to licensed prescribers following these evidence-based protocols.
GLP-1SemaglutideTirzepatideLean Plan
Testosterone + Hormones
TRT improves energy, muscle mass, libido, and mood in hypogonadal men
AUA guidelines (2022) and Testosterone Trials (NEJM 2016) confirm significant improvements in sexual function, physical capacity, and bone density with TRT in men with low testosterone. OceanicScore's hormonal sub-score flags eligibility for clinical evaluation.
TRTTestosteroneHormone OptimizationAlpha Plan
NAD+ + Longevity
NAD+ declines ~50% between age 40 and 60 — precursor supplementation reverses this
Yoshino et al. (Cell Metabolism 2021) demonstrated that NMN supplementation significantly increased muscle NAD+ levels and improved insulin sensitivity in older adults. NAD+ precursor protocols form the core of the Sharp plan's longevity stack.
NAD+NMNNRLongevitySharp Plan
Chiropractic + Spine
Spinal manipulation is as effective as NSAIDs for acute low back pain
Cochrane Review (2011, updated 2023) and JAMA (2017) confirm that spinal manipulation produces short-term improvements in pain and function comparable to NSAIDs for acute and subacute low back pain, with fewer adverse effects. The Restore plan includes 2 adjustments per month with a matched local provider.
ChiropracticSpineBack PainRestore Plan
Peptide Bioregulators
Short-chain peptide bioregulators show tissue-specific regenerative activity
Khavinson et al. research from the St. Petersburg Institute of Bioregulation demonstrates that short-chain peptide bioregulators (dipeptides, tripeptides) exert tissue-specific effects on gene expression and cellular function. Atumnus has developed a proprietary portfolio of Ac-X-NH2 analogs targeting these pathways.
PeptidesBioregulatorsCellularElite Plan
Omega-3 + Inflammation
EPA/DHA at 3g/day reduces inflammatory markers and cardiovascular risk
REDUCE-IT trial (NEJM 2018) demonstrated 25% reduction in major cardiovascular events with 4g/day icosapentaenoic acid. Meta-analyses confirm dose-dependent reductions in triglycerides, CRP, and IL-6 with omega-3 supplementation at therapeutic doses.
Omega-3EPADHAInflammationFoundation
See the science in your score.
4-minute assessment · validated instruments · evidence-based outputs